Skip to main content

Table 5 Clinical characteristics, use of therapeutic procedures and hospital outcomes after propensity score matching (PSM) for men and women with T2DM hospitalized with STEMI and NSTEMI

From: Are there sex differences in the effect of type 2 diabetes in the incidence and outcomes of myocardial infarction? A matched-pair analysis using hospital discharge data

 

STEMI

NSTEMI

T2DM Men

T2DM Women

p-value

T2DM Men

T2DM Women

p-value

STEMI involving left main coronary artery, n (%)

41 (0.58)

32 (0.46)

0.291

NA

NA

–

STEMI involving left anterior descending coronary artery, n (%)

768 (10.95)

689 (9.82)

0.029

NA

NA

–

STEMI involving other coronary artery of anterior wall, n (%)

1766 (25.17)

1796 (25.6)

0.554

NA

NA

–

STEMI involving right coronary artery, n (%)

859 (12.24)

771 (10.99)

0.021

NA

NA

–

STEMI involving other coronary artery of inferior wall, n (%)

1687 (24.05)

1729 (24.64)

0.403

NA

NA

–

STEMI involving left circumflex coronary artery, n (%)

96 (1.37)

94 (1.34)

0.885

NA

NA

–

STEMI involving other sites, n (%)

394 (5.62)

390 (5.56)

0.886

NA

NA

–

STEMI of unspecified site, n (%)

1405 (20.03)

1515 (21.59)

0.024

NA

NA

–

NSTEMI n (%)

NA

NA

–

8204 (100)

8204 (100)

NA

Age, mean (SD)

74.64 (10.77)

75.87 (11.43)

< 0.001

76.26 (9.90)

76.94 (10.33)

< 0.001

CCI, mean (SD)

0.74 (0.66)

0.72 (0.65)

0.191

0.87 (0.85)

0.83 (0.80)

0.011

Obesity, n (%)

1183 (16.86)

1246 (17.76)

0.160

1561 (19.03)

1767 (21.54)

< 0.001

Hypertension, n (%)

4273 (60.9)

4242 (60.46)

0.592

4699 (57.28)

4695 (57.23)

0.950

Lipid metabolism disorders, n (%)

3945 (56.23)

3939 (56.14)

0.919

4879 (59.47)

4944 (60.26)

0.301

Renal disease, n (%)

1127 (16.06)

1159 (16.52)

0.464

1902 (23.18)

1878 (22.89)

0.656

Atrial fibrillation, n (%)

1134 (16.16)

1217 (17.35)

0.061

1572 (19.16)

1647 (20.08)

0.140

Congestive heart failure, n (%)

1651 (23.53)

1875 (26.72)

< 0.001

2070 (25.23)

2324 (28.33)

< 0.001

Peripheral vascular disease, n (%)

320 (4.56)

310 (4.42)

0.684

491 (5.98)

548 (6.68)

0.068

Cerebrovascular disease, n (%)

347 (4.95)

376 (5.36)

0.268

420 (5.12)

487 (5.94)

0.022

Dementia, n (%)

204 (2.91)

334 (4.76)

< 0.001

187 (2.28)

288 (3.51)

< 0.001

Mechanical ventilation, n (%)

506 (7.21)

490 (6.98)

0.599

395 (4.81)

389 (4.74)

0.826

CABG, n (%)

84 (1.2)

52 (0.74)

0.006

266 (3.24)

209 (2.55)

0.008

PCI, n (%)

3813 (54.35)

3267 (46.56)

< 0.001

3222 (39.27)

2715 (33.09)

< 0.001

LOHS, median (IQR)

5 (5)

5.00 (5.00)

0.121

6 (6)

6.00 (6.00)

0.467

In-hospital mortality, n (%)

787 (11.22)

1095 (15.61)

< 0.001

529 (6.45)

602 (7.34)

0.025

  1. STEMI ST-elevation myocardial infarction, CCI Charlson comorbidity index, CABG coronary artery bypass graft, PCI percutaneous coronary intervention, LOHS length of hospital stay, NA not applicable
  2. The P values for the differences between patients with T2DM and No T2DM were calculated using Student’s t-test, or Mann–Whitney test or chi-square tests